<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32(3)</volume><submitter>Falcon D</submitter><funding>Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía</funding><funding>State Agency of Research</funding><pubmed_abstract>The upregulation of Orai1 and subsequent store-operated Ca&lt;sup>2+&lt;/sup> entry (SOCE) has been associated with adverse cardiac remodeling and heart failure (HF). However, the mechanism underlying Orai1 upregulation and its role in myocardial infarction remains unclear. Our study investigated the role of Orai1 in activating adenylyl cyclase 8 (AC8) and cyclic AMP (cAMP) response element-binding protein (CREB), as well as its contribution to cardiac dysfunction induced by ischemia and reperfusion (I/R). We found that I/R evoked an increase in the expression of Orai1 and AC8 in rats' hearts, resulting in a substantial rise in diastolic Ca&lt;sup>2+&lt;/sup> concentration ([Ca&lt;sup>2+&lt;/sup>]&lt;sub>i&lt;/sub>), and reduced ventricular contractions. The expression of Orai1 and AC8 was also increased in ventr</pubmed_abstract><journal>Molecular therapy : the journal of the American Society of Gene Therapy</journal><pagination>646-662</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10928147</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Inhibition of adenylyl cyclase 8 prevents the upregulation of Orai1 channel, which improves cardiac function after myocardial infarction.</pubmed_title><pmcid>PMC10928147</pmcid><pubmed_authors>Dominguez-Rodriguez A</pubmed_authors><pubmed_authors>Falcon D</pubmed_authors><pubmed_authors>Gutierrez-Carretero E</pubmed_authors><pubmed_authors>Rosado JA</pubmed_authors><pubmed_authors>Martin-Bornez M</pubmed_authors><pubmed_authors>Smani T</pubmed_authors><pubmed_authors>Mayoral-Gonzalez I</pubmed_authors><pubmed_authors>Ordonez-Fernandez A</pubmed_authors><pubmed_authors>Calderon-Sanchez EM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of adenylyl cyclase 8 prevents the upregulation of Orai1 channel, which improves cardiac function after myocardial infarction.</name><description>The upregulation of Orai1 and subsequent store-operated Ca&lt;sup>2+&lt;/sup> entry (SOCE) has been associated with adverse cardiac remodeling and heart failure (HF). However, the mechanism underlying Orai1 upregulation and its role in myocardial infarction remains unclear. Our study investigated the role of Orai1 in activating adenylyl cyclase 8 (AC8) and cyclic AMP (cAMP) response element-binding protein (CREB), as well as its contribution to cardiac dysfunction induced by ischemia and reperfusion (I/R). We found that I/R evoked an increase in the expression of Orai1 and AC8 in rats' hearts, resulting in a substantial rise in diastolic Ca&lt;sup>2+&lt;/sup> concentration ([Ca&lt;sup>2+&lt;/sup>]&lt;sub>i&lt;/sub>), and reduced ventricular contractions. The expression of Orai1 and AC8 was also increased in ventr</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T10:42:12.389Z</modification><creation>2025-04-04T10:42:12.389Z</creation></dates><accession>S-EPMC10928147</accession><cross_references><pubmed>38291755</pubmed><doi>10.1016/j.ymthe.2024.01.026</doi></cross_references></HashMap>